S&P 500 index futures are up 0.1% as U.S. retail sales rose in July, but less than expected.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
On the global stage, markets traded near record highs as investors looked ahead to the high-stakes summit between President Trump and Russia’s President, Vladimir Putin, in Alaska. Expectations of progress on Ukraine and a potential thaw in global tensions are underpinning cautious optimism across equity markets.
In pre-market trading, S&P 500 futures are up 0.11%, Nasdaq futures are down 0.09% and Dow futures are up 0.58%
Check out this morning’s top movers from around Wall Street, compiled by The Fly, and subscribe to the Fly By on YouTube.
HIGHER –
- Precigen (PGEN) up 49% after announcing that the FDA has granted full approval to Papzimeos for the treatment of adults with recurrent respiratory papillomatosis
- United Health (UNH), Lennar (LEN) and D.R. Horton (DHI) up 10%, 3% and 3%, respectively, after the disclosure of Warren Buffett’s Berkshire Hathaway holding stakes in the companies
- Intel (INTC) up 3% in a follow-through to yesterday’s strength after Bloomberg reported that the Trump administration is in talks to have the U.S. government potentially take a stake in the chipmaker to support efforts to expand domestic manufacturing
UP AFTER EARNINGS –
DOWN AFTER EARNINGS –
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on UNH:
- Berkshire Hathaway Boosts Stake in UnitedHealth Stock (UNH) and Cuts AAPL and Bank of America in Q2
- UnitedHealth Stock (UNH) Is Trending Higher as Warren Buffett Reveals New Stake – Will the Rally Continue?
- Why Warren Buffett and Hedge Funds Are Betting on UnitedHealth Stock (UNH)
- M&A News: UnitedHealth (UNH) Closes $3.3B Amedisys Deal After Two-Year Antitrust Battle
- Closing Bell Movers: UnitedHealth jumps 10% as Berkshire, Appaloosa buy weakness